CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced
Integrating In Silico Tools with Organ-on-a-Chip to advance ADME studies
Knowing a drug’s bioavailability during lead optimization is crucial as it directly influences dosing strategy, therapeutic efficacy, safety margins,
NIH to prioritize human-based research technologies & reduce animal use in research
During the FDA-NIH Workshop: Reducing Animal Testing, held on July 7, 2025, Dr. Nicole Kleinstreuer, Acting NIH Deputy Director for Program
CN Bio to participate in 3Rs Collaborative-led project with FDA to build confidence in Liver MPS for DILI
Building Confidence in MPS for Regulatory Applications! At the intersection of innovation, collaboration, and science lies an exciting new
CN Bio introduces cross-species DILI services to enhance in vitro to in vivo extrapolation during preclinical drug development
CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion CN Bio, a
Microphysiological systems for mAbs development: how do they address animal limitations?
Welcome to part two of our blog series exploring the FDA’s announcement to phase out the animal testing requirement for monoclonal antibodies (mAbs),
Why the FDA animal testing phase-out for monoclonal antibodies?
In a groundbreaking press release on April 10th, 2025, the FDA announced its decision to phase out animal testing requirements for monoclonal
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
CN Bio and Pharmaron partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel